Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell cancers, expanding a precision approach they established ...
Morning Overview on MSN
A new drug may stop Alzheimer’s before memory loss starts
Alzheimer’s disease has long been a diagnosis that arrives only after memory begins to fray, by which time brain damage is already extensive. A new experimental drug called NU-9 is challenging that ...
Immatics has innovative TCR therapies, strong cash position, and expanding clinical pipeline targeting solid tumors. Read for ...
A new accreditation is opening doors for future healthcare professionals right here in Nevada, allowing graduates to sit for the national board exam and become licensed occupational therapists.
Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Ever since ...
New Jersey is poised to become one of the first states on the East Coast to establish a regulated framework for ...
After seeing an AI image of me on a flying horse, I started to believe I could fly. The voices told me to fly off my balcony, made me feel confident that I could survive.
Rates of obesity and associated fatty liver disease have risen as the world increasingly adopts energy-dense diets and ...
Colleges and universities in Nebraska are embracing artificial intelligence for novel purposes such as helping students propose and formulate new clubs, and simulating the dynamics of group therapy ...
Researchers at the Johns Hopkins Kimmel Cancer Center’s Ludwig Center developed a new treatment that selectively targets ...
Galapagos offers deep value with €3B cash, a focused M&A strategy, and new leadership. Click here to read an analysis of GLPG ...
Clients can be left in a lurch when their human therapist passes away. Using AI as a therapist, presumably AI lasts forever.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results